Article info
Editorial commentary
Glial fibrillary acidic protein: a blood biomarker to differentiate neurodegenerative from psychiatric diseases
- Correspondence to Dr Henrik Zetterberg, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, Goteborg S-431 80, Sweden; henrik.zetterberg{at}clinchem.gu.se
Citation
Glial fibrillary acidic protein: a blood biomarker to differentiate neurodegenerative from psychiatric diseases
Publication history
- Received August 2, 2021
- Accepted August 21, 2021
- First published September 3, 2021.
Online issue publication
January 07, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.